Data / Drug companies / Aspen Oss B.V.
Aspen Oss B.V.: 46 products in the FDA NDC directory, labeler code 60870
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Aspen Oss B.V. (labeler code 60870) lists 46 products in the FDA National Drug Code Directory. By type: 46 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on April 1, 2022.
The request: Watch Aspen Oss B.V. (FDA labeler code 60870): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 60870
- Products in commercial distribution
- 46
- Packages
- 46
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule III 7
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 28, 1977
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 46 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 46 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Estrogens, conjugated | 60870-0479 | Powder | Bulk ingredients | April 1, 2022 |
| Heparin | 60870-0473 | Powder | Bulk ingredients | November 21, 2021 |
| Ganirelix acetate | 60870-0476 | Powder | Bulk ingredients | August 16, 2021 |
| Etonogestrel | 60870-0475 | Powder | Bulk ingredients | July 26, 2021 |
| Segesterone acetate | 60870-0474 | Powder | Bulk ingredients | July 1, 2021 |
| Heparin | 60870-0467 | Powder | Bulk ingredients | March 17, 2020 |
| Sugammadex | 60870-0464 | Powder | Bulk ingredients | April 1, 2015 |
| Asenapine maleate | 60870-0468 | Powder | Bulk ingredients | March 12, 2015 |
| Leuprolide | 60870-0471 | Powder | Bulk ingredients | June 11, 2014 |
| Mirtazapine | 60870-0117 | Powder | Bulk ingredients | July 21, 2008 |
| Altrenogest | 60870-0456 | Powder | Bulk ingredients | January 3, 2003 |
| Testosterone undecanoate | 60870-0465 | Powder | Bulk ingredients | November 18, 1999 |
| Desogestrel | 60870-0460 | Powder | Bulk ingredients | August 2, 1999 |
| Desmopressin | 60870-0440 | Powder | Bulk ingredients | July 28, 1999 |
| Oxytocin | 60870-0438 | Powder | Bulk ingredients | July 28, 1999 |
| Testosterone cypionate | 60870-0252 | Powder | Bulk ingredients | June 18, 1999 |
| Gonadorelin diacetate tetrahydrate | 60870-0436 | Powder | Bulk ingredients | January 21, 1999 |
| Rimexolone | 60870-0423 | Powder | Bulk ingredients | May 29, 1997 |
| Rocuronium bromide | 60870-0450 | Powder | Bulk ingredients | August 14, 1996 |
| Leuprolide | 60870-0472 | Powder | Bulk ingredients | April 19, 1996 |
| Leuprolide acetate | 60870-0425 | Powder | Bulk ingredients | April 19, 1996 |
| Estrogens, conjugated | 60870-0422 | Powder | Bulk ingredients | July 3, 1995 |
| Budesonide | 60870-0466 | Powder | Bulk ingredients | September 23, 1993 |
| Gonadorelin acetate | 60870-0478 | Powder | Bulk ingredients | May 4, 1993 |
| Hydroxyprogesterone caproate | 60870-0408 | Powder | Bulk ingredients | January 9, 1992 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.